Literature DB >> 7959659

Interpretation of large intestinal mucosal biopsy specimens.

H Goldman1.   

Abstract

The development of flexible endoscopes has led to a great increase in the examination and mucosal biopsy evaluation of all portions of the large intestine and rectum. Examinations are now performed not only for the determination of diagnosis but also for the monitoring of the course of a wide variety of conditions and for the early detection of complications. This review concentrates on the uses and interpretations of such biopsies in a large number of inflammatory conditions, with special emphasis on the correlations with clinical and functional features. Illustrated are examples of infections, idiopathic inflammatory bowel disease (IBD), vascular disorders, motor and mechanical conditions, toxic and physical reactions, and other inflammatory conditions. Mucosal biopsy specimens also are obtained to identify dysplasia and to evaluate mass lesions, and these subjects are well covered in other articles within this symposium. In patients with chronic disorders multiple examinations are now expected to follow the course of the disease and to detect and correct any complications at an early stage. The exact reasons for the endoscopy and relevant clinical data are essential for the optimal analysis of these mucosal biopsy specimens.

Entities:  

Mesh:

Year:  1994        PMID: 7959659     DOI: 10.1016/0046-8177(94)90031-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.

Authors:  B Moum; A Ekbom; M H Vatn; E Aadland; J Sauar; I Lygren; T Schulz; N Stray; O Fausa
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

2.  Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative.

Authors:  D Jenkins; M Balsitis; S Gallivan; M F Dixon; H M Gilmour; N A Shepherd; A Theodossi; G T Williams
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

Review 3.  Influence of treatment on morphological features of mucosal inflammation.

Authors:  K Geboes; I Dalle
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.

Authors:  K Geboes; R Riddell; A Ost; B Jensfelt; T Persson; R Löfberg
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

5.  Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis.

Authors:  A B Pulimood; B S Ramakrishna; G Kurian; S Peter; S Patra; V I Mathan; M M Mathan
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Autofluorescence imaging endoscopy for identification and assessment of inflammatory ulcerative colitis.

Authors:  Taro Osada; Atsushi Arakawa; Naoto Sakamoto; Hiroya Ueyama; Tomoyoshi Shibuya; Tatsuo Ogihara; Takashi Yao; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

7.  PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.

Authors:  Kathrin Ludwig; Matteo Fassan; Claudia Mescoli; Marco Pizzi; Mariangela Balistreri; Laura Albertoni; Salvatore Pucciarelli; Marco Scarpa; Giacomo Carlo Sturniolo; Imerio Angriman; Massimo Rugge
Journal:  Virchows Arch       Date:  2012-12-08       Impact factor: 4.064

8.  Prospective audit of mucosal biopsy specimens of the gastrointestinal tract.

Authors:  P M Stephenson; P J Gallagher
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

9.  Elevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps.

Authors:  Zarko Babic; Vjekoslav Jagić; Zvonko Petrović; Ante Bilić; Kapetanović Dinko; Goranka Kubat; Rosana Troskot; Mira Vukelić
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 10.  Assessing Severity of Disease in Patients with Ulcerative Colitis.

Authors:  Baldeep Singh Pabla; David Allen Schwartz
Journal:  Gastroenterol Clin North Am       Date:  2020-09-23       Impact factor: 3.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.